Table 3. Metabolic rates at fasting without and with normoglycemic hyperinsulinemic clamp.
Experimental phases | P * | ||||||
Groups | No clamp | Clamp | Protocol | Group | Protocol x group | Group difference | |
CHOox (µmol/min) | FH− | 941±128 | 1548±136 | <0.001 | 0.002 | 0.30 | T2D≠FH− |
FH+ | 745±130 | 1355±155 | |||||
T2D | 625±159 | 855±124 | |||||
FATox (µmol/min) | FH− | 254±25 | 121±15 | <0.001 | <0.001 | 0.52 | T2D≠others |
FH+ | 255±31 | 138±35 | |||||
T2D | 389±40 | 319±26 | |||||
Glycerol (µmol/l) | FH− | 75±4 | 36±3 | <0.001 | 0.003 | 0.78 | T2D≠others |
FH+ | 77±7 | 35±6 | |||||
T2D | 100±10 | 52±8 | |||||
Raglycerol (µmol/min) | FH− | 284±33 | 141±17 | <0.001 | 0.01 | 0.83 | T2D≠FH+ |
FH+ | 235±29 | 141±33 | |||||
T2D | 368±53 | 244±61 | |||||
Palmitate (µmol/l) | FH− | 145±13 | 21±6 | <0.001 | 0.007 | 0.18 | T2D≠FH− |
FH+ | 201±22 | 22±3 | |||||
T2D | 210±24 | 52±10 | |||||
Oleate (µmol/l) | FH− | 206±15 | 19±2 | <0.001 | 0.008 | 0.42 | T2D≠FH− |
FH+ | 250±24 | 38±6 | |||||
T2D | 280±29 | 50±7 | |||||
Linoleate (µmol/l) | FH− | 76±6 | 17±2 | <0.001 | 0.005 | 0.13 | T2D≠FH− |
FH+ | 107±9 | 20±2 | |||||
T2D | 107±12 | 29±3 |
*P values are from two-way ANOVAs with Scheffe's post-hoc test for difference between groups. Differences between groups remained significant after adjustment for gender. Adjustment for age or BMI abolished group difference in triacylglycerol and glycerol levels. Adjustment for waist circumference abolished group differences in triacylglycerol, glycerol, glycerol appearance rate and oleate levels.
CHOox: net carbohydrate oxidation rate; FATox: net fatty acid oxidation rate; FH−: no family history of type 2 diabetes; FH+: offspring of both parents with type 2 diabetes; NEFA: nonesterified fatty acids; Raglycerol: glycerol appearance rate; T2D: subjects with type 2 diabetes; TG: triacylglycerol.